02629

12.4100.00%
HC

Hou Chiat Ho

Chief Investment Officer

Mr. Hou Chiat Ho, also known as Isaac, is Chief Investment Officer of Mirxes Holding Company Limited since November 25, 2020 and served as its Executive Director since July 2023 until November 13, 2025. He served as Director of Mirxes Holding Company Limited since November 25, 2020 until July 2023. Mr. Ho has also held positions at other members of our Group, including MiRXES Singapore, MiRXES Health, Early Medical Pte. Ltd., Early Ascent Pte. Ltd., Early Vista Pte. Ltd., Early Diagnostics Pte. Ltd. and Singapore Health Diagnostics Pte. Ltd. He has been a director and the chief investment officer of MiRXES Singapore since March 2018. Prior to joining our Group, Mr. Ho founded VentureCraft Holdings Pte. Ltd. (formerly known as Singapore Health Holdings Pte. Ltd.) in July 2014 and acted as its director and chief executive officer from July 2014 to June 2018. Mr. Ho serves as a Director of Ark Bio Holding Pte. Ltd., which held the major operating subsidiaries of our Group, namely MiRXES Singapore, MiRXES Lab and M Diagnostics, prior to the Reorganization. See “History, Reorganization and Corporate Structure” for further details of the relationship between Ark Bio Holding Pte. Ltd. Mr. Ho obtained the Diploma in Manufacturing Engineering from Nanyang Polytechnic, Singapore, in May 1996. He obtained his Bachelor of Commerce degree in management and marketing from Deakin University, Australia, in April 2005. Mr. Ho was awarded the EY Entrepreneur of The Year™ Singapore by Ernst & Young in 2021.

Positions